Virtual versus usual in-office care for multiple sclerosis: The VIRTUAL-MS multi-site randomized clinical trial study protocol

McGinley, Marisa; Carlson, Josh J.; Reihm, Jennifer; Plow, Matthew; Roser, Megan; Sisodia, Nikki; Cohen, Jeffrey A.; Misra-Hebert, Anita D.; Lazar, Ann A.; Bove, Riley

doi:10.1016/j.cct.2024.107544

Cited by 2 publications

(3 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The efficacy of telemedicine in managing chronic diseases is well-supported by numerous studies [ 21 - 23 , 30 - 33 , 39 , 40 , 46 ]. For example, a retrospective evaluation of telehealth pharmacy services revealed increased pharmacy visits and A1c (blood test for diagnosis of type 1 and type 2 diabetes) reductions among most patients, indicating effective diabetes management through telehealth platforms [ 31 ].…”

Section: Reviewmentioning

confidence: 99%

“…McGinley et al explored the long-term effects of telemedicine on multiple sclerosis (MS) management [ 30 ]. Their study compares in-clinic and telemedicine approaches over a 24-month period, evaluating clinical outcomes, economic implications, patient satisfaction, and treatment adherence.…”

Section: Reviewmentioning

confidence: 99%

“…The findings highlight telemedicine's potential to improve access and patient experiences while maintaining effective clinical outcomes. These insights can guide future strategies in MS care and clinical trial designs, emphasizing telemedicine's role in reducing healthcare delivery barriers and enhancing patient outcomes [ 30 ].…”

Section: Reviewmentioning

confidence: 99%

See 2 more Smart Citations

Revolutionizing Healthcare: How Telemedicine Is Improving Patient Outcomes and Expanding Access to Care

Ezeamii,

Okobi,

Wambai-Sani

et al. 2024

Cureus

View full text Add to dashboard Cite

Telemedicine uses digital technologies to provide healthcare services remotely, greatly improving patient access, especially during crises like the COVID-19 pandemic. This systematic review investigates telemedicine's effects on patient outcomes, access to care, and its role in the evolving healthcare landscape. Relevant studies were identified using MeSH terms and keywords through electronic databases and manual reference list screenings. The selected empirical studies, both quantitative and qualitative, examined telemedicine across various patient populations. The review categorized findings into themes related to patient outcomes and access to care.Telemedicine was found to be a transformative tool in chronic disease management, particularly in diabetes care. Significant improvements in patient health outcomes and cost savings were reported with telemedicine interventions. For example, telehealth platforms enhance diabetes management by increasing patient engagement and improving clinical metrics such as HbA1c levels. Additionally, telehealth services for diabetes-related foot disease (DFD) overcome geographical barriers, providing specialized care and improving patient access and satisfaction.In conclusion, telemedicine significantly improves patient outcomes, access, and satisfaction in chronic disease management, especially diabetes care. By overcoming geographical barriers and enhancing patient engagement, telehealth platforms have the potential to transform global healthcare delivery. Implementing these insights into practice can improve the accessibility and effectiveness of diabetes care worldwide, ensuring equitable and patient-centered healthcare solutions.

show abstract

Section: Reviewmentioning

confidence: 99%

Section: Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Revolutionizing Healthcare: How Telemedicine Is Improving Patient Outcomes and Expanding Access to Care

Ezeamii,

Okobi,

Wambai-Sani

et al. 2024

Cureus

View full text Add to dashboard Cite

show abstract

Improving Access to MS Care Through Technology

McGinley

2024

Mult Scler

View full text Add to dashboard Cite

People with multiple sclerosis (PwMS) experience many barriers to accessing multiple sclerosis (MS) care that lead to diagnostic delays, delayed treatment, interrupted care, and significant economic burden. These barriers include limited geographic healthcare resources, financial burden, physical limitations, and inequities within the healthcare system. Telemedicine has the potential to reduce these barriers and improve access to care. The lack of geographic proximity to neurologists and MS Centers can be overcome by leveraging telemedicine which has been shown to significantly reduce travel burden. Furthermore, cross-sectional studies have shown telemedicine reduces indirect costs for PwMS including significantly lower mean costs in parking, gas, tolls, and wages lost compared to in-person visits. Although there has been evidence that telemedicine can reduce many barriers there is still a need to demonstrate the impact of longitudinal telemedicine care and its direct impact on access to MS care.

show abstract

Virtual versus usual in-office care for multiple sclerosis: The VIRTUAL-MS multi-site randomized clinical trial study protocol

Cited by 2 publications

References 46 publications

Revolutionizing Healthcare: How Telemedicine Is Improving Patient Outcomes and Expanding Access to Care

Revolutionizing Healthcare: How Telemedicine Is Improving Patient Outcomes and Expanding Access to Care

Improving Access to MS Care Through Technology

Contact Info

Product

Resources

About